Form 4 Tracker
HALOZYME THERAPEUTICS, INC.
HALO

42 insider filings · Latest: Oct 6, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 18, 2024Sep 18 8:01 PMMICHAEL LABARRE
Proposed Sale
10,000$62.03$620.3K—

View →

Sep 17, 2024Sep 17 8:03 PMMICHAEL LABARRE
Proposed Sale
10,000$62.88$628.8K—

View →

Sep 12, 2024Sep 12 8:12 PMHELEN TORLEY
Proposed Sale
10,000$59.20$592.0K—

View →

Sep 11, 2024Sep 11 8:05 PMHELEN TORLEY
Proposed Sale
10,000$59.09$590.9K—

View →

Sep 10, 2024Sep 10 8:16 PMHELEN TORLEY
Proposed Sale
10,000$59.09$590.9K—

View →

← Previous

Page 4 of 4

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 13, 2026May 13 9:50 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
10,000$12.0751,923(D)

View →

May 12, 2026May 13 9:50 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
20,000$12.0761,923(D)

View →

May 11, 2026May 13 9:50 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
20,000$12.0781,923(D)

View →

May 5, 2026May 7 11:04 PMMatthew L. PosardDirector
Grant/Award
6,040$65.876,040(D)

View →

May 5, 2026May 7 11:04 PMMahesh KrishnanDirector
Grant/Award
6,040$65.876,040(D)

View →

May 5, 2026May 7 11:03 PMJames Paul LangDirector
Grant/Award
6,040$65.876,040(D)

View →

May 5, 2026May 7 11:02 PMJeffrey William HendersonDirector
Grant/Award
6,040$65.876,040(D)

View →

May 5, 2026May 7 11:02 PMBarbara Gayle DuncanDirector
Grant/Award
6,040$65.876,040(D)

View →

May 5, 2026May 7 11:01 PMBernadette ConnaughtonDirector
Grant/Award
6,040$65.876,040(D)

View →

Apr 6, 2026Apr 7 9:13 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
10,000$12.07101,923(D)

View →

Apr 1, 2026Apr 2 10:29 PMDavid A RamsayInterim CFO
Grant/Award
10,000$0.0010,000(D)

View →

Apr 2, 2026Apr 2 10:28 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
20,000$12.07111,923(D)

View →

Apr 1, 2026Apr 2 10:28 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
20,000$12.07131,923(D)

View →

Mar 10, 2026Mar 10 11:18 PMCortney CaudillSVP, CHIEF OPERATING OFFICER
Option Exercise
1,546$33.5167,678(D)

View →

Mar 9, 2026Mar 10 11:18 PMCortney CaudillSVP, CHIEF OPERATING OFFICER
Option Exercise
20,000$33.5169,224(D)

View →

Mar 4, 2026Mar 4 11:56 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
10,000$12.07151,923(D)

View →

Mar 3, 2026Mar 4 11:56 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
20,000$12.07161,923(D)

View →

Mar 2, 2026Mar 4 11:56 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
20,000$12.07181,923(D)

View →

Feb 20, 2026Feb 24 11:19 PMCortney CaudillSVP, CHIEF OPERATING OFFICER
Option Exercise
2,666$0.007,998(D)

View →

Feb 23, 2026Feb 24 11:16 PMMark Howard SnyderSVP, CHIEF LEGAL OFFICER
Option Exercise
7,011$0.0014,022(D)

View →